TG Therapeutics
TGTX
#3345
Rank
A$6.36 B
Marketcap
A$40.08
Share price
-4.67%
Change (1 day)
-24.47%
Change (1 year)

Earnings for TG Therapeutics (TGTX)

Earnings in 2025 (TTM): A$0.17 Billion

According to TG Therapeutics's latest financial reports the company's current earnings are A$0.53 Billion. In 2024 the company made an earning of A$71.82 Million, an increase over its 2023 earnings that were of A$37.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for TG Therapeutics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.17 B148.42%
2024 A$71.82 M93.76%
2023 A$37.06 M-113.65%
2022 -A$0.28 Billion-45.06%
2021 -A$0.5 Billion25.42%
2020 -A$0.4 Billion62.93%
2019 -A$0.25 Billion-3.34%
2018 -A$0.26 Billion46.05%
2017 -A$0.18 Billion48.38%
2016 -A$0.12 Billion29.09%
2015 -A$89.48 Million12.99%
2014 -A$79.19 Million180.92%
2013 -A$28.19 Million
2009 -A$2.56 Million-59.85%
2008 -A$6.38 Million
2006 -A$14.44 Million-48.34%
2005 -A$27.95 Million215.12%
2004 -A$8.87 Million29.1%
2003 -A$6.87 Million159.59%
2002 -A$2.65 Million
2000 -A$4.55 Million12.38%
1999 -A$4.05 Million7.69%
1998 -A$3.76 Million-49.02%
1997 -A$7.37 Million82.14%
1996 -A$4.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Alkermes
ALKS
A$0.58 B 252.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Dr. Reddy's Laboratories
RDY
A$1.32 B 699.08%๐Ÿ‡ฎ๐Ÿ‡ณ India